Marchant DJ - Search Results

1

Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.

Hendry RG, Bilawchuk LM, Marchant DJ. Hendry RG, et al. Among authors: marchant dj. J Cardiovasc Transl Res. 2014 Mar;7(2):212-25. doi: 10.1007/s12265-013-9528-2. Epub 2014 Jan 1. J Cardiovasc Transl Res. 2014. PMID: 24381086 Review.

2

Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.

Cheung C, Marchant D, Walker EK, Luo Z, Zhang J, Yanagawa B, Rahmani M, Cox J, Overall C, Senior RM, Luo H, McManus BM. Cheung C, et al. Circulation. 2008 Mar 25;117(12):1574-82. doi: 10.1161/CIRCULATIONAHA.107.733238. Epub 2008 Mar 10. Circulation. 2008. PMID: 18332263

3

Matrix metalloproteinases in the pathogenesis of viral heart disease.

Marchant D, McManus BM. Marchant D, et al. Trends Cardiovasc Med. 2009 Jan;19(1):21-6. doi: 10.1016/j.tcm.2009.04.001. Trends Cardiovasc Med. 2009. PMID: 19467450 Review.

4

Virus-induced signaling influences endosome trafficking, virus entry, and replication.

Marchant DJ, Bilawchuk L, Nish G, Hegele RG. Marchant DJ, et al. Methods Enzymol. 2014;534:65-76. doi: 10.1016/B978-0-12-397926-1.00004-4. Methods Enzymol. 2014. PMID: 24359948

5

A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity.

Marchant DJ, Bellac CL, Moraes TJ, Wadsworth SJ, Dufour A, Butler GS, Bilawchuk LM, Hendry RG, Robertson AG, Cheung CT, Ng J, Ang L, Luo Z, Heilbron K, Norris MJ, Duan W, Bucyk T, Karpov A, Devel L, Georgiadis D, Hegele RG, Luo H, Granville DJ, Dive V, McManus BM, Overall CM. Marchant DJ, et al. Nat Med. 2014 May;20(5):493-502. doi: 10.1038/nm.3508. Epub 2014 Apr 28. Nat Med. 2014. PMID: 24784232

6

Coxsackievirus B3 replication and pathogenesis.

Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, Shi J, McManus BM. Garmaroudi FS, et al. Future Microbiol. 2015;10(4):629-53. doi: 10.2217/fmb.15.5. Future Microbiol. 2015. PMID: 25865198 Free article. Review.

7

Emerging pharmacologic targets and treatments for myocarditis.

Jensen LD, Marchant DJ. Jensen LD, et al. Among authors: marchant dj. Pharmacol Ther. 2016 May;161:40-51. doi: 10.1016/j.pharmthera.2016.03.006. Epub 2016 Mar 20. Pharmacol Ther. 2016. PMID: 27009690 Review.

8

The Susceptibilities of Respiratory Syncytial Virus to Nucleolin Receptor Blocking and Antibody Neutralization are Dependent upon the Method of Virus Purification.

Bilawchuk LM, Griffiths CD, Jensen LD, Elawar F, Marchant DJ. Bilawchuk LM, et al. Among authors: marchant dj. Viruses. 2017 Aug 3;9(8):207. doi: 10.3390/v9080207. Viruses. 2017. PMID: 28771197 Free PMC article.

9

A Virological and Phylogenetic Analysis of the Emergence of New Clades of Respiratory Syncytial Virus.

Elawar F, Griffiths CD, Zhu D, Bilawchuk LM, Jensen LD, Forss L, Tang J, Hazes B, Drews SJ, Marchant DJ. Elawar F, et al. Among authors: marchant dj. Sci Rep. 2017 Sep 25;7(1):12232. doi: 10.1038/s41598-017-12001-6. Sci Rep. 2017. PMID: 28947776 Free PMC article.

10

IGF1R is an entry receptor for respiratory syncytial virus.

Griffiths CD, Bilawchuk LM, McDonough JE, Jamieson KC, Elawar F, Cen Y, Duan W, Lin C, Song H, Casanova JL, Ogg S, Jensen LD, Thienpont B, Kumar A, Hobman TC, Proud D, Moraes TJ, Marchant DJ. Griffiths CD, et al. Among authors: marchant dj. Nature. 2020 Jul;583(7817):615-619. doi: 10.1038/s41586-020-2369-7. Epub 2020 Jun 3. Nature. 2020. PMID: 32494007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page